Skip to main content
Bioceltix S.A. logo

Bioceltix S.A. — Investor Relations & Filings

Ticker · BCX ISIN · PLBCLTX00019 LEI · 259400QZD5JYK8SLZU51 WAR Manufacturing
Open in API
Filings indexed 270 across all filing types
Latest filing 2023-02-14 Proxy Solicitation & In…
Country PL Poland
Listing WAR BCX

About Bioceltix S.A.

https://bioceltix.com/en/

Bioceltix S.A. is a biopharmaceutical company that develops stem cell-based medicinal products for veterinary use. The company focuses on creating therapies that utilize Mesenchymal Stem Cells (MSCs) as the active pharmaceutical ingredient. Its product pipeline is aimed at treating immunological and inflammatory conditions in companion animals, including dogs, cats, and horses. A key area of development includes treatments for conditions such as atopic dermatitis in dogs and degenerative joint disease.

Recent filings

Filing Released Lang Actions
Wzór pełnomocnictwa dla akcjonariusza
Proxy Solicitation & Information Statement Classification · 1% confidence The document text is titled "WZÓR PEŁNOMOCNICTWA" (Power of Attorney Template) and details the granting of authority to a representative to participate and vote on behalf of a shareholder ("Akcjonariusz") at an Extraordinary General Meeting of Shareholders ("Nadzywczajnym Walnym Zgromadzeniu Akcjonariuszy") of BIOCELTIX S.A. on March 13, 2023. This document is directly related to shareholder representation and voting rights for a general meeting. This aligns best with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM), or potentially Proxy Solicitation & Information Statement (PSI), which covers materials sent to request votes. Since this is a specific form used to grant voting power for a meeting, it is most closely associated with the mechanics of the general meeting itself. Given the options, AGM-R (AGM Information) is the most appropriate fit as it covers materials related to the general meeting process, although PSI is also relevant for proxy materials. However, a Power of Attorney form is a core document enabling participation in the meeting, making AGM-R the strongest fit among the provided codes for general meeting materials.
2023-02-14 Polish
Projekt tekstu jednolitego statutu
Governance Information Classification · 1% confidence The document text is titled "Projekt tekstu jednolitego statutu Spółki" (Draft consolidated text of the Company's Articles of Association) and contains detailed sections (§ 1 through § 8A) covering the company's name, seat, scope of activity (PKD codes), share capital structure (including different series of shares, nominal values, and conditional capital), and authorization for capital increases (target capital). This content is characteristic of a company's foundational legal document, the Articles of Association (Statut Spółki). In the context of corporate filings, the Articles of Association or amendments thereto are typically filed as part of major corporate governance updates or registration documents. Since the provided definitions do not have a specific code for 'Articles of Association,' I must select the closest fit. The document details governance structure, capital, and fundamental rules, making 'Governance Information' (CGR) the most appropriate category, as statutes define the core governance framework. It is not an Annual Report (10-K), an Earnings Release (ER), or a simple announcement (RPA/RNS), as it is the substantive legal text itself.
2023-02-14 Polish
Zestawienie zmian statutu
Share Issue/Capital Change Classification · 1% confidence The document text is titled "Zestawienie zmian statutu Spółki" (Statement of changes to the Company's Articles of Association) and details proposed amendments to specific paragraphs (§ 7 and § 8) concerning the share capital ('Kapitał zakładowy') and target capital ('Kapitał docelowy'). These changes involve adjusting the authorized share capital limits, the number of shares, and the expiration date of the board's authorization to issue new shares. This type of document, which formally amends the foundational governing document (Articles of Association/Statute) of a company, is directly related to the company's capital structure and financing framework. Among the provided codes, 'Capital/Financing Update' (CAP) is the most appropriate fit, as it covers changes to capital structure, although 'Share Issue/Capital Change' (SHA) is also relevant. However, since this is a formal amendment to the statute governing future capital actions (including target capital provisions), CAP is slightly broader and fits the context of a structural change announcement better than a simple transaction report (SHA/POS). Given the nature of amending the statute regarding share capital, CAP is selected.
2023-02-14 Polish
Opinia Zarządu dot. akcji serii K
Capital/Financing Update Classification · 1% confidence The document is titled "OPINIA ZARZĄDU BIOCELTIX S.A. UZASADNIAJĄCA POWODY POZBAWIENIA AKCJONARIUSZY PRAWA POBORU AKCJI SERII K..." (Opinion of the Management Board of Bioceltix S.A. Justifying the Reasons for Depriving Shareholders of Pre-emptive Rights for Series K Shares...). It explicitly discusses the proposed capital increase, the exclusion of pre-emptive rights (prawo poboru), the pricing mechanism, and the purpose of raising funds (financing development projects). This content directly relates to corporate financing activities, specifically a new share issue and the associated capital structure change, which aligns with the 'Capital/Financing Update' definition. While it involves a shareholder meeting (NWZ), the core subject is the financing mechanism itself, not the meeting results or general AGM materials. Therefore, 'CAP' is the most appropriate classification.
2023-02-14 Polish
Projekty uchwał wraz z uzasadnieniem
AGM Information Classification · 1% confidence The document consists of multiple resolutions ('Uchwała nr 01/03/2023', 'Uchwała nr 02/03/2023', etc.) passed by an Extraordinary General Meeting ('Nadzwyczajne Walne Zgromadzenie') of BIOCELTIX S.A. on March 13, 2023. The resolutions specifically deal with electing a chairman, approving the agenda, increasing share capital ('podwyższenia kapitału zakładowego') through the issuance of new shares (Series K) while excluding pre-emptive rights, and amending the company's articles of association ('zmiany statutu'). These actions are typical outcomes of a shareholder meeting, often documented in minutes or resolutions related to the meeting itself. Since the content details the specific decisions made during the meeting, it aligns best with the materials presented or resulting from an Annual General Meeting (AGM) or Extraordinary General Meeting (EGM). The closest category is AGM-R (AGM Information), as it contains the formal resolutions passed at such a gathering.
2023-02-14 Polish
Ogłoszenie o zwołaniu NWZA
AGM Information Classification · 1% confidence The document is titled "OGŁOSZENIE O ZWOŁANIU NWZA BIOCELTIX S.A. NA DZIEŃ 13 MARCA 2023 ROKU" which translates to "ANNOUNCEMENT OF THE CONVENING OF AN EXTRAORDINARY GENERAL MEETING (EGM) OF BIOCELTIX S.A. FOR MARCH 13, 2023". The text details the date, time, location, and detailed agenda for this meeting, including resolutions regarding capital increase and changes to the company's articles of association. This content is characteristic of a formal notice calling for a shareholder meeting, which falls under the scope of AGM/EGM related materials. Since the document is a notice convening a meeting (not the results or the presentation itself), and it specifically deals with the procedures and agenda for a General Meeting, the most appropriate classification is AGM-R (AGM Information), as it relates directly to the preparation and convening of the meeting.
2023-02-14 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.